comparemela.com

Latest Breaking News On - Rani therapeutics holdings - Page 3 : comparemela.com

Individual investors own 40% of Rani Therapeutics Holdings, Inc (NASDAQ:RANI) shares but private companies control 47% of the company

Key Insights Rani Therapeutics Holdings' significant private companies ownership suggests that the key decisions are.

Wedbush Comments on Rani Therapeutics Holdings, Inc s FY2027 Earnings (NASDAQ:RANI)

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Equities researchers at Wedbush decreased their FY2027 earnings per share (EPS) estimates for Rani Therapeutics in a research note issued to investors on Tuesday, February 6th. Wedbush analyst A. Argyrides now anticipates that the company will post earnings of ($1.78) per share for the year, down […]

Purcell & Lefkowitz LLP Announces Shareholder Investigation of Rani Therapeutics Holdings, Inc (NASDAQ: RANI) -January 09, 2024 at 08:31 am EST

NEW YORK, Jan. 9, 2024 /PRNewswire/ Purcell & Lefkowitz LLP announces that it is investigating Rani Therapeutics Holdings, Inc. on behalf of the company s shareholders.  The investigation seeks.

Rani Therapeutics (RANI) Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Rani Therapeutics (RANI) Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rani Therapeutics Holdings, Inc (NASDAQ:RANI) CEO Talat Imran Buys 5,000 Shares

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) CEO Talat Imran acquired 5,000 shares of the stock in a transaction on Monday, December 4th. The stock was purchased at an average cost of $2.57 per share, with a total value of $12,850.00. Following the transaction, the chief executive officer now directly owns 474,455 shares […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.